Washington Trust Bank cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the period. Vertex Pharmaceuticals comprises approximately 1.3% of Washington Trust […]
Washington Trust Bank lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 36,061 shares of the pharmaceutical company’s stock after selling 2,315 shares during the quarter. Vertex Pharmaceuticals comprises approximately 1.3% of […]
Stamos Capital Partners L.P. lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 56.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,240 shares of the pharmaceutical company’s stock after selling 1,630 shares […]
Epoch Investment Partners Inc. grew its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 358,916 shares of the pharmaceutical company’s stock after purchasing an additional 10,059 shares during the period. Epoch […]
Joseph Group Capital Management increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 9.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,748 shares of the pharmaceutical company’s stock after buying an additional 310 shares during […]